Celularity, Inc. (CELU)
1.23
-0.02
(-1.60%)
USD |
NASDAQ |
Feb 12, 16:00
1.21
-0.02
(-1.63%)
After-Hours: 20:00
Celularity Free Cash Flow : -8.113M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Organogenesis Holdings, Inc. | -51.65M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.159M |
| Cash from Financing (Quarterly) | 3.478M |
| Free Cash Flow Per Share (Quarterly) | -0.1579 |
| Free Cash Flow to Equity (Quarterly) | -0.767M |
| Free Cash Flow to Firm (Quarterly) | -2.682M |
| Free Cash Flow Yield | -27.41% |